FDA warns against combination of malaria drug and Gilead's remdesivir
June 15, 2020 at 16:46 PM EDT
The U.S. Food and Drug Administration on Monday issued a warning to healthcare providers against administering malaria drug hydroxychloroquine or chloroquine in combination with Gilead Sciences' experimental COVID-19 drug, remdesivir.
